CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: Diverse effect on subsequent synthesis of tumor necrosis factor α and nitric oxide

Microbes and Infection

Volumn 8, Issue 5, 2006, Pages 1209-1218

  Pan, Wanling ^a   Ogunremi, Oladele ^b   Wei, Guojian ^a   Shi, Meiqing ^a   Tabel, Henry ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

African trypanosomes; Antibody; CD11b; Complement; Congolense; CR3; Immunoglobulin M; Macrophage; Nitric oxide; Phagocytosis; Trypanosoma; Tumor necrosis factor

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR CR3; IMMUNOGLOBULIN M ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INCUBATION TIME; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE; TRYPANOSOMA; TRYPANOSOMA CONGOLENSE; WILD TYPE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, CD11B; ANTIGENS, CD18; FEMALE; HUMANS; IMMUNOGLOBULIN M; MACROPHAGE-1 ANTIGEN; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; PHAGOCYTOSIS; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

MURINAE; TRYPANOSOMA CONGOLENSE;

EID: 33744796798     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.11.009     Document Type: Article

References (63)

1. Mulligan H.W., and Potts W.H. The African Trypanosomiases (1970), Wiley-Intersciences, a Division of John Wiley and Sons, Inc, New York
2. Cross G.A. Cellular and genetic aspects of antigenic variation in trypanosomes. Annu. Rev. Immunol. 8 (1990) 83-110
3. Greenwood B.M., and Whittle H.C. Cerebrospinal-fluid IgM in patients with sleeping-sickness. Lancet 2 (1973) 525-527
4. Binz G., Timperman G., and Hutchinson M.P. Estimation of serum immunoglobulin M as a screening technique for trypanosomiasis. A field trial in the Democratic Republic of the Congo. Bull. World Health Organ. 38 (1968) 523-545
5. Clarkson M.J. IgM in Trypanosoma brucei infection of different strains of mice. Parasitology 73 (1976)
6. Hudson K.M., Byner C., Freeman J., and Terry R.J. Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis. Nature 264 (1976) 256-258
7. Luckins A.G. The immune response of zebu cattle infection with Trypanosoma congolense and T. vivax. Ann. Trop. Med. Parasitol. 70 (1976) 133-145
8. Campbell G.H., Esser K.M., and Phillips S.M. Trypanosoma rhodesiense infection in congenitally athymic (nude) mice. Infect. Immun. 20 (1978) 714-720
9. Pinder M., Chassin P., and Fumoux F. Mechanisms of self-cure from Trypanosoma congolense infection in mice. J. Immunol. 136 (1986) 1427-1434
10. Reinitz D.M., and Mansfield J.M. Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins. J. Immunol. 141 (1988) 620-626
11. Uzonna J.E., Kaushik R.S., Gordon J.R., and Tabel H. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol. 21 (1999) 57-71
12. DeGee A.L., and Mansfield J.M. Genetics of resistance to the African trypanosomes. IV. Resistance of radiation chimeras to Trypanosoma rhodesiense infection. Cell. Immunol. 87 (1984) 85-91
13. Dempsey W.L., and Mansfield J.M. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J. Immunol. 130 (1983) 405-411
14. Macaskill J.A., Holmes P.H., Whitelaw D.D., McConnell I., Jennings F.W., and Urquhart G.M. Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. Immunology 40 (1980) 629-635
15. Shi M., Wei G., Pan W., and Tabel H. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells. J. Leukoc. Biol. 76 (2004) 399-405
16. Shi M., Pan W., and Tabel H. Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Eur. J. Immunol. 33 (2003) 108-118
17. Askonas B.A. Macrophages as mediators of immunosuppression in murine African trypanosomiasis. Curr. Top. Microbiol. Immunol. 117 (1985) 119-127
18. Noel W., Hassanzadeh G., Raes G., Namangala B., Daems I., Brys L., Brombacher F., Baetselier P.D., and Beschin A. Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect. Immun. 70 (2002) 6180-6187
19. Shi M., Wei G., Pan W., and Tabel H. Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infect. Immun. 73 (2005) 8393-8396
20. Kaushik R.S., Uzonna J.E., Gordon J.R., and Tabel H. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice. Exp. Parasitol. 92 (1999) 131-143
21. Law S.K., and Reid K.B. Complement 9 (1988), IRl Press 11-12
22. Shakibaei M., and Frevert U. Cell surface interactions between Trypanosoma congolense and macrophages during phagocytosis in vitro. J. Protozool. 39 (1992) 224-235
23. Greenblatt H.C., Diggs C.L., and Aikawa M. Antibody-dependent phagocytosis of Trypanosoma rhodesiense by murine macrophages. Am. J. Trop. Med. Hyg. 32 (1983) 34-45
24. Flemmings B., and Diggs C. Antibody-dependent cytotoxicity against Trypanosoma rhodesiense mediated through an alternative complement pathway. Infect. Immun. 19 (1978) 928-933
25. Malu M.N., and Tabel H. The alternative pathway of complement in sheep during the course of infection with Trypanosoma congolense and after Berenil treatment. Parasite Immunol. 8 (1986) 217-229
26. Otesile E.B., Lee M., and Tabel H. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections. J. Parasitol. 77 (1991) 958-964
27. Cain J.A., Newman S.L., and Ross G.D. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast. Complement 4 (1987) 75-86
28. May R.C., and Machesky L.M. Phagocytosis and the actin cytoskeleton. J. Cell Sci. 114 (2001) 1061-1077
29. Preynat-Seauve O., Villiers C.L., Jourdan G., Richard M.J., Plumas J., Favier A., Marche P.N., and Favrot M.C. An interaction between CD16 and CR3 enhances iC3b binding to CR3 but is lost during differentiation of monocytes into dendritic cells. Eur. J. Immunol. 34 (2004) 147-155
30. Rosenthal L.A., Sutterwala F.S., Kehrli M.E., and Mosser D.M. Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect. Immun. 64 (1996) 2206-2215
31. Ross G.D., Cain J.A., and Lachmann P.J. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134 (1985) 3307-3315
32. Aggarwal B.B., and Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7 (1996) 93-124
33. Magez S., Radwanska M., Beschin A., Sekikawa K., and De Baetselier P. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun. 67 (1999) 3128-3132
34. Duleu S., Vincendeau P., Courtois P., Semballa S., Lagroye I., Daulouede S., Boucher J.L., Wilson K.T., Veyret B., and Gobert A.P. Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect. J. Immunol. 172 (2004) 6298-6303
35. Gobert A.P., Semballa S., Daulouede S., Lesthelle S., Taxile M., Veyret B., and Vincendeau P. Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes. Infect. Immun. 66 (1998) 4068-4072
36. Vincendeau P., Daulouede S., Veyret B., Darde M.L., Bouteille B., and Lemesre J.L. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75 (1992) 353-360
37. Tabel H. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol. 4 (1982) 329-335
38. Lanham S.M., and Godfrey D.G. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28 (1970) 521-534
39. Kremmer E., Thierfelder S., Felber E., Hoffmann-Fezer G., and Wasiliu M. Monoclonal antibodies to complement components without the need of their prior purification. II. Antibodies to mouse C3 and C4. Hybridoma 9 (1990) 309-317
40. Wei G., Qualtiere L., and Tabel H. Trypanosoma congolense: complement independent immobilization by a monoclonal antibody. Exp. Parasitol. 70 (1990) 483-485
41. Nilsson B., Ekdahl K.N., Svensson K.E., Bjelle A., and Nilsson U.R. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera. Mol. Immunol. 26 (1989) 383-390
42. Ogunremi O., Tabel H., Kremmer E., and Wasiliu M. Differences in the activity of the alternative pathway of complement in BALB/c and C57Bl/6 mice. Exp. Clin. Immunogenet. 10 (1993) 31-37
43. Aderem A., and Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17 (1999) 593-623
44. Linehan S.A., Martinez-Pomares L., and Gordon S. Macrophage lectins in host defence. Microbes Infect. 2 (2000) 279-288
45. Tabel H., Kaushik R.S., and Uzonna J.E. Susceptibility and resistance to Trypanosoma congolense infections. Microbes Infect. 2 (2000) 1619-1629
46. Sternberg J., Mabbott N., Sutherland I., and Liew F.Y. Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect. Immun. 62 (1994) 2135-2137
47. Ross G.D. Opsonization and membrane complement receptors. In: Ross G.D. (Ed). Immunobiology of the Complement System, An Introduction for Research and Clinical Medicine 87 (1986), Academic Press, Orlando
48. Yan J., Vetvicka V., Xia Y., Hanikyrova M., Mayadas T.N., and Ross G.D. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Immunopharmacology 46 (2000) 39-54
49. Le Cabec V., Carreno S., Moisand A., Bordier C., and Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J. Immunol. 169 (2002) 2003-2009
50. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., Eyre H.J., Sutherland G.R., Endo Y., Fujita T., Miyabayashi T., Sakano S., Tsuji T., Nakayama E., Phillips J.H., Lanier L.L., and Nakauchi H. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1 (2000) 441-446
51. Liu E.W., Otesile E.B., and Tabel H. Immune lysis of Trypanosoma congolense: generation of a soluble covalent complex of variant surface glycoprotein and bovine complement component C3b. Vet. Immunol. Immunopathol. 38 (1993) 169-181
52. Gerold P., Striepen B., Reitter B., Geyer H., Geyer R., Reinwald E., Risse H.J., and Schwarz R.T. Glycosyl-phosphatidylinositols of Trypanosoma congolense: two common precursors but a new protein-anchor. J. Mol. Biol. 261 (1996) 181-194
53. Magez S., Stijlemans B., Baral T., and De Baetselier P. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect. 4 (2002) 999-1006
54. Levy O., Jean-Jacques R.M., Cywes C., Sisson R.B., Zarember K.A., Godowski P.J., Christianson J.L., Guttormsen H.K., Carroll M.C., Nicholson-Weller A., and Wessels M.R. Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect. Immun. 71 (2003) 6344-6353
55. Moore K.J., Andersson L.P., Ingalls R.R., Monks B.G., Li R., Arnaout M.A., Golenbock D.T., and Freeman M.W. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 165 (2000) 4272-4280
56. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., and Gazzinelli R.T. Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
57. Hunter C.A., Gow J.W., Kennedy P.G., Jennings F.W., and Murray M. Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice. Infect. Immun. 59 (1991) 4636-4640
58. Okomo-Assoumou M.C., Daulouede S., Lemesre J.L., N'Zila-Mouanda A., and Vincendeau P. Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. Am. J. Trop. Med. Hyg. 53 (1995) 539-543
59. Sileghem M., Flynn J.N., Logan-Henfrey L., and Ellis J. Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol. 16 (1994) 51-54
60. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., and Ross G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156 (1996) 1235-1246
61. Coller S.P., Mansfield J.M., and Paulnock D.M. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J. Immunol. 171 (2003) 1466-1472
62. Vincendeau P., and Daulouede S. Macrophage cytostatic effect on Trypanosoma musculi involves an l-arginine-dependent mechanism. J. Immunol. 146 (1991) 4338-4343
63. Hertz C.J., and Mansfield J.M. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell Immunol. 192 (1999) 24-32